• What is unique about the oncology patient experience and how do we approach that?
• What is specifically unique or challenging for your patient population?
• What concepts can be transferred from other therapies that can be useful for optimizing oncology therapies?
• What are some specific initiatives, campaigns, techniques or technologies that are improving oncology patient experiences?
Dani Girardi, Senior Therapeutic Specialist, Oncology,
Gilead Sharon H. Streets, BSN, RN, Director of Treatment Operations,
AdaptimmuneJosh Konetzni, VP and Head of Business Development, VMS BioMarketing